Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Smithers

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Annals of Surgery|July 19, 2016
Long-term Health-related Quality of Life Following Esophagectomy: A Nonrandomized Comparison of Thoracoscopically Assisted and Open SurgeryAndrew P Barbour, Orla M Mc Cormack, Peter J Baker, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 6, 2023
The association between BRAF-V600E mutations and death from thin (≤1.00 mm) melanomas: A nested case-case study from Queensland, AustraliaM Claeson, S X Tan, D Lambie, et al.
The British Journal of Dermatology|December 4, 2019
The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controlsE K McMeniman, D L Duffy, K Jagirdar, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 14, 2004
Chemoradiation therapy is effective for the palliative treatment of malignant dysphagiaJ A Harvey, J R Bessell, E Beller, et al.
Internal Medicine Journal|September 3, 2015
Building a sustainable clinical academic workforce to meet the future healthcare needs of Australia and New Zealand: report from the first summit meetingJ Windsor, J Searle, R Hanney, et al.
The Journal of Investigative Dermatology|August 18, 2019
Genes Determining Nevus Count and Dermoscopic Appearance in Australian Melanoma Cases and ControlsDavid L Duffy, Kasturee Jagirdar, Katie J Lee, et al.
Annals of Surgical Oncology|September 14, 2019
Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of LifeMichael A Henderson, D Gyorki, B H Burmeister, et al.
BMC Cancer|March 16, 2022
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinomaR Mercieca-Bebber, E H Barnes, K Wilson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trialA P Barbour, E T Walpole, G T Mai, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 13, 2016
Worldwide Esophageal Cancer Collaboration: pathologic staging dataT W Rice, L-Q Chen, W L Hofstetter, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Annals of Surgery|July 19, 2016
Long-term Health-related Quality of Life Following Esophagectomy: A Nonrandomized Comparison of Thoracoscopically Assisted and Open SurgeryAndrew P Barbour, Orla M Mc Cormack, Peter J Baker, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 6, 2023
The association between BRAF-V600E mutations and death from thin (≤1.00 mm) melanomas: A nested case-case study from Queensland, AustraliaM Claeson, S X Tan, D Lambie, et al.
The British Journal of Dermatology|December 4, 2019
The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controlsE K McMeniman, D L Duffy, K Jagirdar, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 14, 2004
Chemoradiation therapy is effective for the palliative treatment of malignant dysphagiaJ A Harvey, J R Bessell, E Beller, et al.
Internal Medicine Journal|September 3, 2015
Building a sustainable clinical academic workforce to meet the future healthcare needs of Australia and New Zealand: report from the first summit meetingJ Windsor, J Searle, R Hanney, et al.
The Journal of Investigative Dermatology|August 18, 2019
Genes Determining Nevus Count and Dermoscopic Appearance in Australian Melanoma Cases and ControlsDavid L Duffy, Kasturee Jagirdar, Katie J Lee, et al.
Annals of Surgical Oncology|September 14, 2019
Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of LifeMichael A Henderson, D Gyorki, B H Burmeister, et al.
BMC Cancer|March 16, 2022
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinomaR Mercieca-Bebber, E H Barnes, K Wilson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trialA P Barbour, E T Walpole, G T Mai, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 13, 2016
Worldwide Esophageal Cancer Collaboration: pathologic staging dataT W Rice, L-Q Chen, W L Hofstetter, et al.
Pageof 12